Aptose Biosciences Inc APTO Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125

09:32 EDT 1 Aug 2017 | BioPortfolio Report Blog

Aptose Biosciences Inc APTO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Aptose Biosciences Inc Aptose is a clinicalstage biotechnology company which focuses on diagnostics, therapies and treatment for patients with lifethreatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion diagnostics to identify patient with cancer. Its small molecule cancer therapeutics pipeline includes products which are designed to provide single agent efficacy and efficacy of other anticancer therapies and regimens without overlapping toxicities. The company's product pipeline comprises of CG'806, is a noncovalent small molecule therapeutic agent, which is under preclinical stage; APTO253 currently under clinical hold is a small molecule with potent antitumor activity in cancer cells. Aptose is headquartered in Mississauga, Ontario, Canada

Aptose Biosciences Inc Key Recent Developments

May 11,2017: Aptose Reports Results for the First Quarter Ended March 31, 2017
Mar 28,2017: Aptose Reports Fourth Quarter and Year End 2016 Results
Mar 27,2017: Aptose Announces Planned Departure of Chief Business Officer
Nov 14,2016: Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016
Aug 09,2016: Aptose Biosciences Reports Financial Results For The Second Quarter Ended June 30, 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Aptose Biosciences Inc APTO Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125


More From BioPortfolio on "Aptose Biosciences Inc APTO Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...